Large-scale testing (Phase 3)Ended earlyNCT04474925What this trial is testingPre- Versus Post-operative SRS for Resectable Brain MetastasesWho this might be right forBrain Metastases AHS Cancer Control Alberta 8
Early research (Phase 1)Study completedNCT00003484What this trial is testingRadiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain TumorsWho this might be right forBrain and Central Nervous System TumorsNeuroblastoma Darell D. Bigner, MD, PhD 21
Large-scale testing (Phase 3)Active Not RecruitingNCT05438212What this trial is testingComparing the Addition of Radiation Either Before or After Surgery for Patients With Brain MetastasesWho this might be right forMetastatic Malignant Neoplasm in the Brain NRG Oncology 237
Early research (Phase 1)Looking for participantsNCT06914479What this trial is testingVirus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain TumorsWho this might be right forRecurrent Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Malignant Brain NeoplasmResectable Brain Neoplasm University of Michigan Rogel Cancer Center 11
Not applicableLooking for participantsNCT06090903What this trial is testingMagnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable GlioblastomaWho this might be right forGlioblastomaRecurrent GlioblastomaResectable Glioblastoma Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT01814813What this trial is testingVaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by SurgeryWho this might be right forRecurrent GlioblastomaRecurrent Adult Brain TumorGliosarcoma Alliance for Clinical Trials in Oncology 90
Very early researchStudy completedNCT05704933What this trial is testingPilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain MetastasesWho this might be right forMetastatic MelanomaMetastasis to Brain H. Lee Moffitt Cancer Center and Research Institute 1
Large-scale testing (Phase 3)WithdrawnNCT00083447What this trial is testingStudy of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme Xenova Biomedix 323
Early research (Phase 1)Study completedNCT00036972What this trial is testingImmunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01679743What this trial is testingGRN1005 for Brain Metastases From Breast or Lung CancerWho this might be right forBreast CancerLung NeoplasmsBreast Neoplasms+1 more National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06650163What this trial is testingZr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain TumorsWho this might be right forGliomaMalignant Brain NeoplasmMeningioma+1 more Jonsson Comprehensive Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT02844387What this trial is testingSupplementation of L-arginine in Patients With Non-resectable Brain MetastasesWho this might be right forUnresectable Multiple Brain Metastases Instituto de Oncología Ángel H. Roffo 70
Testing effectiveness (Phase 2)Ended earlyNCT04434560What this trial is testingNeoadjuvant Immunotherapy in Brain MetastasesWho this might be right forBrain Metastases, Adult Sarah Sammons, MD 1
Large-scale testing (Phase 3)Study completedNCT00088400What this trial is testingComparison of TransMID vs Standard Treatment of Cancerous Brain TumorsWho this might be right forGlioblastoma National Institute of Neurological Disorders and Stroke (NINDS) 30
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00003461What this trial is testingRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain TumorsWho this might be right forBrain and Central Nervous System TumorsMetastatic CancerNeuroblastoma Duke University
Not applicableStudy completedNCT00002485What this trial is testingDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more Children's Oncology Group 359
Not applicableStudy completedNCT00040911What this trial is testingElectroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin LymphomaWho this might be right forBrain TumorsCentral Nervous System TumorsChildhood Germ Cell Tumor+8 more Children's Oncology Group 17
Testing effectiveness (Phase 2)WithdrawnNCT00814593What this trial is testingLymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by SurgeryWho this might be right forBrain and Central Nervous System Tumors Lisata Therapeutics, Inc.